Here choose a group of games, from different angles training, physical development among children of flexibility and coordination. Easy to use, simple and appropriate in the family do.
Game 1: Long Arm game
Objective: To cultivate children's ability of flexible
Material: Trouser
Method: Wear the trouser with hand as "Long Arm"monster, then who was touched by the trouser are considered lose.
Recommendations: start playing, so that children can run free hand, parents who do the long arm. And then swap roles, then the transition to chase each other.
GAne 2: Mountain climbing
Objective: To train children in his leg strength.
Material: the use of public housing opportunities.
Method: Assuming te stairs is the mountain. Then parent lead the children to clamb the mountain. When all are success climb up the "Peak" and cheers: "We have to Peak!"
Suggestions: Parents should pay attention to protection. According to a high degree of endurance and gradually increase the difficulty to children's physical exercise and athletic ability.
Gme 3: "Acrobatic performances"
Objective: To train children's waiste and abdominal.
Material: plastic bottles, rope and thin bamboo pole.
Preparation: parents and children together to get through bottle-shaped into a sleeve. do some colouring or drawing on it, and then rope it up or use the thin bamboo pole to string up sleeves. Then just fix it accoring to the high of parents or children to sit for an encounter with their feet to fit.
Method: Parents sit on the carpet, with his legs kick the sleeve bottle to rotate the sleeve to show the their child. Then, lower down the high of the sleeve, so that children can also do this "acrobatic performances."
Little children mental development by playing game (Part 1)
Lung cancer - major factors
Lung cancer mainly on the occurrence of lung cancer smoking, occupational (in close contact with asbestos, radon gas, mustard gas, polycyclic aromatic hydrocarbons compounds, chlorine ether, chromium, nickel, inorganic arsenic compounds, as well as radiation, etc.), air pollution (the air pollution contains a large number of motor vehicle exhaust, burning waste) factors. There are other factors: dietary vitamin A and other analogues (vitamin A) in the content related to the occurrence of lung cancer, chronic lung diseases (such as chronic bronchitis, pulmonary tuberculosis), genetic factors.
The incidence of lung cancer is very complex factors. However, the two major factors ca be summarized as below:
First, environmental carcinogens factors.
With industrial development, air pollution has become a major problem, such as nitrosamines, asbestos, chrome, nickel, mustard gas, arsenic, bitumen, oil and other emissions…… spread in the air, the water enters the human body has become an important factor carcinogenic ;
Second, the individual factors to smoking is the most important factor.
Smoking index greater than 400 and obviously the incidence of lung cancer, smoking index for smoke daily count by the number of years of smoking. Some scholars study, smokers than non-smokers of lung cancer 8.8 times the rate. Tobacco-specific carcinogenic substances containing N-nitroso drop smoke pH, it is a Central nitrosamines, after activation, can be carcinogenic substances, carcinogenic mutations performance.
Breast Cancer - Classification
Breast cancers are described along four different classification schemes, or groups, each based on different criteria and serving a different purpose:
Pathology - A pathologist will categorize each tumor based on its histological (microscopic anatomy) appearance and other criteria. The most common pathologic types of breast cancer are invasive ductal carcinoma, malignant cancer in the breast's ducts, and invasive lobular carcinoma, malignant cancer in the breast's lobules.
Grade of tumor - The histological grade of a tumor is determined by a pathologist under a microscope. A well-differentiated (low grade) tumor resembles normal tissue. A poorly differentiated (high grade) tumor is composed of disorganized cells and, therefore, does not look like normal tissue. Moderately differentiated (intermediate grade) tumors are somewhere in between.
Protein & gene expression status - Currently, all breast cancers should be tested for expression, or detectable effect, of the estrogen receptor (ER), progesterone receptor (PR) and HER2/neu proteins. These tests are usually done by immunohistochemistry and are presented in a pathologist's report. The profile of expression of a given tumor helps predict its prognosis, or outlook, and helps an oncologist choose the most appropriate treatment. More genes and/or proteins may be tested in the future.
Stage of a tumour - The currently accepted staging scheme for breast cancer is the TNM classification.
There are five tumor classification values (Tis, T1, T2, T3 or T4) which depend on the presence or absence of invasive cancer, the dimensions of the invasive cancer, and the presence or absence of invasion outside of the breast (e.g. to the skin of the breast, to the muscle or to the rib cage underneath):
Tx - Primary tumor cannot be assessed.
T0 - No evidence of primary tumor.
Tis - Carcinoma in situ.
Tis(DCIS) - Intracuctal Carcinoma in situ.
Tis(LCIS) - Lobular Carcinoma in situ.
Tis(Paget's) - Paget's disease of the nipple with no tumor.
T1 - Tumor 2cm or less in its greatest dimension.
T1mic - Microinvasion 0.1cm or less in greatest dimension.
T1a - Tumor more then 0.1cm but not more than 0.5cm in its greatest dimension.
T1b - Tumor more than 0.5cm but not more than 1.0cm in its greatest dimension.
T1c - Tumor more than 1.0cm but not more than 2.0cm in its greatest dimension.
T2 - Tumor more than 2.0cm but not more than 5.0cm in its greatest dimension.
T3 - Tumor more than 5cm in its greatest dimension.
T4 - Tumor of any size with direct extension to (a) chest wall or (b) skin as described below:
T4a - Extension to chest wall.
T4b - Edema (including peau d'orange) or ulceration of the breast skin, or satellite skin nodules confined to the same breast.
T4c - Both T4a and T4b.
T4d - Inflammatory breast cancer.
Lymph Node - There are four lymph node classification values (N0, N1, N2 or N3) which depend on the number, size and location of breast cancer cell deposits in lymph nodes.
Nx - regional lymph nodes cannot be assessed. Perhaps due to previous removal.
N0 - no regional lymph node metastasis.
N1 - metastasis to movable regional axillary lymph nodes on the same side as the effected breast.
N2 - metastasis to fixed regional axillary lymph nodes, or metastasis to the internal mammary lymph nodes, on the same side as the effected breast.
N3 - metastasis to supraclavicular lymph nodes or infraclavicular lymph nodes or metastasis to the internal mammary lymph nodes with metastasis to the axillary lymph nodes.
Metastases - There are two metastatic classification values (M0 or M1) which depend on the presence or absence of breast cancer cells in locations other than the breast and lymph nodes (so-called distant metastases, e.g. to bone, brain, lung).
Originally from Wikipedia.org
Breast Cancer - Introduction
Breast cancer is a cancer that starts in the cells of the breast.
Worldwide, breast cancer is the second most common type of cancer after lung cancer (10.4% of all cancer incidence, both sexes counted) and the fifth most common cause of cancer death. Worldwide, breast cancer is by far the most common cancer amongst women, with an incidence rate more than twice that of colorectal cancer and cervical cancer and about three times that of lung cancer. However breast cancer mortality worldwide is just 25% greater than that of lung cancer in women. In 2005, breast cancer caused 502,000 deaths worldwide (7% of cancer deaths; almost 1% of all deaths).The number of cases worldwide has significantly increased since the 1970s, a phenomenon partly blamed on modern lifestyles in the Western world.
The incidence of breast cancer varies greatly around the world being lower in less developed countries and greatest in the more developed countries. In the twelve world regions the annual age standardised incidence per 100,000 women are in Eastern Asia 18, South Central Asia 22, 
sub-Saharan Africa 22, South-Eastern Asia 26, North Africa and Western Asia 28, South and Central America 42, Eastern Europe 49, Southern Europe 56, Northern Europe 73, Oceania 74, Western Europe 78, and in North America 90. In the United States the incidence is 141 among white women and 122 among African American women.
North American women have the highest incidence of breast cancer in the world. Among women in the U.S., breast cancer is the most common cancer and the second-most common cause of cancer death (after lung cancer). Women in the U.S. have a 1 in 8 (12.5%) lifetime chance of developing invasive breast cancer and a 1 in 35 (3%) chance of breast cancer causing their death. In 2007, breast cancer was expected to cause 40,910 deaths in the U.S. (7% of cancer deaths; almost 2% of all deaths).
In the U.S., 
both incidence and death rates for breast cancer have been declining in the last few years. Nevertheless, a U.S. study conducted in 2005 by the Society for Women's Health Research indicated that breast cancer remains the most feared disease, even though heart disease is a much more common cause of death among women.
Because the breast is composed of identical tissues in males and females, breast cancer also occurs in males. Incidences of breast cancer in men are approximately 100 times less common than in women, but men with breast cancer are considered to have the same statistical survival rates as women.
Originally from Wikipedia.org
Governmental Reforms are needed to ward of hospital infections in the United Sates
This time the government of the United States needs to tie up their belts and must take every possible step to clear infections in the major hospitals. On April 16th,2008 a report was released which stated clearly that 99,000 people die per year due to hospital infections in the US and that because the Government don’t introduce compulsory practices in hospitals to clear infections. The reports of the Government Accountability office stated that if the government could introduce some restrictions and prior rules to keep hospitals clean. Then it can reduce the future reimbursements because of growing infections and its after-effects.
The U.S. Department of Health and Human Services was strongly accused in the reports because of not synchronizing information across agencies and failing to implement suggested measures. Cynthia Bascetta, director for health issues at the Government Accountability Office claimed that the secretary of the HHS must administer and exercise his/her power to implement necessary reforms.
Experts pointed out that the hospital staffs and the administration are not paid sufficiently and not put under pressures to maintain cleanliness in the hospitals. Another cause is the growing popularity of new technologies and drugs that has weakened the infection prevention and effective care for patients. These must be countered by the US government.
